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Abstract: Despite playing important roles throughout biology, molecular recognition 
mechanisms in intrinsically disordered proteins remain poorly understood. We present a 
combination of 1HN, 13C’ and 15N relaxation dispersion (RD) NMR, measured at multiple 
titration points, to map the interaction between the disordered domain of Sendai virus 
nucleoprotein (NT) and the C-terminal domain of the phosphoprotein (PX). Interaction with 
PX funnels the free-state equilibrium of NT by stabilizing one of the previously identified 
helical sub-states present in the pre-recognition ensemble, in a non-specific and dynamic 
encounter complex on the surface of PX. This helix then locates into the binding site at a rate 
coincident with intrinsic breathing motions of the helical groove on the surface of PX. The 
binding kinetics of complex formation are thus regulated by intrinsic free-state 
conformational dynamics of both proteins. This approach, providing high-resolution 
structural and kinetic information about a complex folding and binding interaction trajectory, 
can be applied to a number of experimental systems to provide a general framework for 
understanding conformational disorder in biomolecular function. 
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INTRODUCTION 
Intrinsically disordered proteins (IDPs) are abundant throughout biology,1–4 in particular in 
eukaryotic proteomes and in some viruses,5 playing crucial roles for example in signaling 
pathways or regulation of transcription and replication.6 Biological function of IDPs is often 
mediated by short sequences of peptides, known as linear motifs, that control a vast range of 
cellular processes through interactions with structured partner proteins.7,8 In spite of the 
ubiquitous nature of IDPs, the exact molecular mechanisms regulating their interactions with 
physiological partners remains poorly understood. This is of prime importance because many 
IDPs are involved in human disease.9 The development of rational pharmacological strategies 
awaits a detailed understanding of the molecular basis of biological interaction and function 
in this extensive but poorly understood fraction of the human proteome. IDPs exhibit highly 
heterogeneous local and long-range structural and dynamic propensities, and this sequence-
dependent conformational behavior is thought to play a key role in regulating function. 
Considerable effort has therefore been devoted to the development of robust approaches to 
describe conformational heterogeneity in IDPs,10–15 and its relationship to functional 
properties such as recognition of physiological partners.16–19 
The relationship between free- and bound-state conformational behaviour is however not 
straightforward,20 as exemplified by the observation of promiscuous IDPs adopting distinct 
conformations of the same binding sites in complex with different interaction partners.21 
Depending on the relative importance of enthalpic and entropic contributions, either pre-
folded or unfolded forms may be considered more likely to mediate binding via 
conformational selection or induced-fit type interactions.22–25 The mechanisms underpinning 
the kinetics of IDP interactions are rendered yet more complex by the suggestion that some 
complexes involving IDPs remain dynamic even in interaction with their partners.26 Although 
a growing body of theoretical,27–30 numerical31–34 and kinetic studies 35–37 have been used to 
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predict or globally characterize molecular recognition in IDPs, these processes remain largely 
unexplored at atomic resolution.38  
NMR studies of interactions involving IDPs are often hampered by excessive line 
broadening, because exchange between free and bound conformations often occurs on time-
scales that give rise to intermediate exchange broadening (in the millisecond range), 
precluding direct detection of the bound-state peaks. It is possible to investigate the origin of 
this line broadening, by detecting the free-state, at low titration admixtures of the partner 
protein, where the resonance-peak is only weakly broadened. Under these conditions, where 
the bound-state represents a weakly populated minor state, relaxation dispersion (RD) 
NMR39,40 can be used to investigate the structure, population and inter-conversion rates of the 
otherwise invisible bound-state equilibrium.16   
In this study we use RD, measured for multiple nuclei (15N, 13C’ and 1HN) and at multiple 
admixtures of the intrinsically disordered C-terminal domain of Sendai virus nucleoprotein 
(NT, residues 401-524) and the partially folded C-terminal head-group of the phosphoprotein 
(PX, residues 474-568), to develop a detailed description of the trajectory from the free state 
equilibrium to the bound-state. Changes in 13C chemical shifts predominantly report on 
changes in secondary structure formation,41 while changes in 15N and 1H shifts are 
particularly sensitive to the tertiary interactions formed at the binding interface of two 
proteins. The combination of these complementary sources of information proves to be 
crucial for describing the intricate interaction pathway. 
Sendai virus belongs to the paramyxoviridae genus, within which the important human 
pathogens Measles, Nipah and Hendra share homologous PX and NT domains.42,43 The 
NT:PX interaction in this viral family is thought to play an essential role in replication in 
vivo, by initiating the interaction between the viral polymerase and genome.44 The NT:PX 
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interaction is central to the viral replication machinery, and as such represents an important 
and viable target for rational drug design in this class of viruses. 
We have previously used NMR residual dipolar couplings to characterize the conformational 
equilibrium of unbound NT, revealing an interaction site sampling three distinct, differently 
populated N-capped45 helical sub-states, in rapid exchange with a completely unfolded 
population.46,47 This linear motif is thought to further fold upon binding to PX,48 on the basis 
of the crystal structure of a chimeric construct of the homologous NT:PX complex from 
Measles virus.49,50 NT is an ideal system with which to investigate folding and binding 
interactions, because of the detailed understanding of the intrinsic conformational sampling 
of the free form of the protein. Our aim is to map the entire interaction trajectory, and in 
particular to determine whether the nature of the free-state ensemble, in particular the 
different pre-folded conformations present comprising the equilibrium, play any role in the 
molecular recognition process. 
RESULTS 
NMR relaxation dispersion studies of the NT:PX interaction 
NMR chemical shift titration studies of the NT:PX complex show that resonances of NT 
from throughout the interaction region (residues 473 to 492) experience line broadening (Fig. 
S1). In this exchange regime NMR titration only provides an estimate of the dissociation 
constant Kd < 60 µM.48 Here we also present isothermal titration calorimetry (ITC) 
measurements, which allow a more precise determination of Kd = 8.4±0.9µM (Fig. S2). In 
order to identify the molecular mechanisms giving rise to the observed broadening of these 
resonances, 15N, 13C’ and 1HN RD experiments were performed on NT (401-524) at two 
magnetic fields (14.1 and 18.8 T) and at admixtures ranging from 0 to 0.15 molar ratios of 
PX (see Methods). No detectable RD is measured in free NT (Fig. S3), confirming the rapid 
nature of the exchange between the three helical sub-states and the unfolded state. However, 
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even at the smallest PX:NT molar ratio (0.02), RD is measured throughout the previously 
identified46,48 molecular recognition element for all three types of nuclei (Fig. 1 and S4). No 
exchange is detectable using RD from regions outside the helical element, for any admixture. 
We note that most resonances from the molecular recognition element are broadened beyond 
detection at PX:NT molar ratios higher than (0.20) (Fig. S5). 
More than 700 experimental RD curves were measured from throughout the molecular 
recognition element. Examination of the measured dispersion curves reveals a complex 
distribution, with clear differences in exchange contributions to R2,eff from the different 
nuclei for distinct peptide units. For example, while backbone carbonyl groups experience 
continuous exchange contributions between residues 474-479, and 486-492, the central 
section of the helical region, comprising residues 480-484, exhibits weaker 13C’ dispersion 
and larger 15N exchange contributions (Fig. 1).  
Analysis of RD data from the molecular recognition site in terms of a two-state binding 
model 
Data were analyzed using the following approaches: Firstly, for each admixture all data from 
each individual peptide plane (15N and 1HN of residue i and 13C’ of residue i-1) in the helical 
region were simultaneously analyzed using a two-site exchange model,51,52 to determine the 
chemical shift differences (Δω) between the free form and the bound state, the residue-
specific exchange rates (kex) and the bound state populations (pB) (Fig S6). The analysis was 
repeated, simultaneously analyzing all data for each individual peptide plane from 2-8% 
admixtures of PX, assuming residue-specific exchange rates (Fig. S7). In both cases a non-
uniform kex is observed along the primary sequence, with rates in the 474-478 and 486-489 
range clustering between 700 and 800s-1, and residues in the central region exhibiting higher 
or lower rates (Fig. 2A). This variability of kex is associated with a non-uniform distribution 
of pB values (Fig. 2B). Importantly, simultaneous analysis of all data at individual titration 
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mixtures using common kex and pB values also demonstrates that while the majority of curves 
are reproduced by kex of 771±38s-1 (Fig. S8) a number of curves, in particular those showing 
large 15N dispersion, are very poorly reproduced (representative examples shown in Fig. 3).  
Analysis of RD data from the molecular recognition site in terms of a three-state binding 
model  
The observation of heterogeneous exchange rates and populations over the helical region, and 
the inability of a global 2-state exchange approach to acceptably reproduce all experimental 
data, suggests that this model is insufficient to explain the NT:PX interaction. We have 
therefore tested linear 3-state exchange models (see Methods). Although the parametric space 
available from such a 3-state fit is ill-defined, inherent degeneracy is raised by the 
combination of the 13C’, 15N and 1HN RD data. As an example, the most complete data set, 
measured at 0.05 PX:NT ratio, provide a convergent fit to a linear exchange model, yielding 
a global minimum centered around kAB=(852±31)s-1 and kBC=(2600±493)s-1, with 
pB=3.7±0.1% and pC=1.3±0.1% (Fig. 4 and Fig. S9). RD data measured at the other 
individual admixtures are closely consistent with this model (Fig. 4). Improvement in data 
reproduction (Fig 3, Table 1) using the more complex model measured over the entire data 
set is statistically significant for all individual molar ratios (p<0.0001 at [PX]/[NT]=0.05, 
0.08, and 0.15; p<0.01 at [PX]/[NT]=0.35, Table 1) with the exception of [PX]/[NT]=0.02, 
probably due to the low amplitude of the RD phenomena at this admixture. Equally 
importantly, fitted pB and pC values for admixtures other then 5% fall closely within the range 
expected from the Kd of the interaction (Fig. 5 and S10). A combined analysis, fitting all 
admixtures simultaneously using a 3-state model, resulted in similar ΔωAB and ΔωAC values 
as the individual admixtures (Fig. S11) and resulted in similar kinetic and theremodynamic 
parameters (kAB=(884±99)s-1 and kBC=(2374±590)s-1,  pB=3.3±0.1% and pC=0.9±0.1% for 
0.05 admixture, see supporting information for remaining admixture populations). 
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Chemical shifts associated with the different steps along the interaction trajectory 
While the first step of the 3-state analysis reproduces features of the best-fit 2-state model 
(ΔωAB, Fig. S12), 13C’ shifts associated with the second step (ΔωAC measured relative to the 
free shifts) are ill-defined for all sites, with the exception for the N and C termini of the helix 
(Fig. S11 and S13). For residues with pronounced 13C’ dispersion in the [PX]/[NT]=0.05 
dataset, ΔωAC values reproduce the ΔωAB pattern (Fig. S14), indicating that change in 13C’ 
chemical shift in the second step (ΔωBC) is close to zero. 13C’ shifts are highly sensitive to 
secondary structural propensity,53 so that the first step is likely associated with a shift in 
helical population. The signs of the 13C’ shift changes were determined using previously 
established approaches,54 revealing that helices are formed (positive Δω) in the A-B step, 
rather than removed (negative Δω), upon interaction (Table S1).  
The second step (B-C), occurring at the faster rate, affects mainly 15N and 1HN RD 
measurements (Fig. 6), with generally significantly larger Δω than in the A-B step. In 
contrast to the 13C shifts, shifts associated with the second step more closely resemble the 2-
state distribution (Fig. S15). Interestingly the 1HN Δω values appear to map the primary 
interaction site of NT with PX, with a pronounced helical periodicity observed along the 
sequence (Fig. 6). Notably, the rate of this step closely corresponds to that of a known 
exchange process intrinsic to PX (kex=(2860±160)s-1) interpreted as a breathing motion of PX 
helices II and III.55 We note that the presence of two distinct steps in the interaction process 
may also explain why resonances of NT remain exchange broadened even in the presence of 
excess PX (Fig. S5). 
Analysis of conformational changes associated with the NT:PX interaction  
The fitted 13C’ Δω values of NT derived from the three-state analysis were added to the free-
state equilibrium isotropic 13C’ shifts to determine the chemical shifts in the B and C states. 
These values were then analyzed in terms of conformation using the minimum ensemble 
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ASTEROIDS approach (see Methods), starting from a single conformational state, and 
iteratively testing for the presence of more complex equilibria if simpler models did not 
adequately reproduce the data.46,47 Comparison of the experimental shifts with values 
predicted from all possible helical ensembles spanning the entire molecular recognition 
element revealed that a single helix (476-489), strongly resembling the H2 helical state (476-
488), is stabilized from the free-state equilibrium (Fig. 7). No significant improvement in the 
data reproduction is achieved when invoking the presence of additional helices in exchange 
with this helix (Fig. S16). The first step of the interaction therefore appears to report on a 
population shift from the free-state equilibrium to this single helical state upon interaction 
with PX. 
Characterization of the NT:PX interaction from the perspective of PX 
15N and 1HN RD was also measured on the partner protein PX upon addition of NT (Fig. 
S17). In agreement with previous results,55 we observe fast conformational exchange in 
several residues within helix III of free PX at a rate of kex=(2860±160)s-1. Titration of NT 
induces additional exchange rates corresponding to those measured on NT for the first step of 
the interaction (803±37)s-1 (Fig. 2C and S18), with the residues involved mapping the 
interaction site of NT along the inter-helical cleft of PX (Fig. 7). 
Estimation of association and dissociation rates, electrostatics and mutation studies 
Estimates based on the experimentally determined Kd and kex indicate an association rate, kon 
in the range of 1.4-4.0･107 M-1s-1 (see Methods) significantly exceeding the diffusion limit,24 
and indicating that electrostatic interactions play a role in initial complex formation. We have 
tested this hypothesis by mutating the negatively charged residues D475 and D478 in the N-
terminal part of the NT interaction region to alanines. The results show a slowing of the 
effective association rate to 4.4･106 M-1s-1, supporting the suggestion that the initial 
encounter complex is electrostatically driven.  
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DISCUSSION 
The high level of detail with which folding and binding events can be mapped using this 
combination of 13C’, 15N and 1HN RD, reveals a probable trajectory for formation of the 
NT:PX complex (Fig. 8). According to this scenario, the interaction pathway follows a two 
step process, initially funneling the existing conformational equilibrium56 via stabilization of 
one of the interconverting helices known to be present in the free-state.46 This step accounts 
for the majority of RD-observed 13C’ chemical shifts, with minimal associated 15N and 1HN 
shifts, suggesting that the initial interaction is non-specific with respect to the surface of PX. 
Although the local conformation of NT (corresponding to helix H2) is well defined during 
the intermediate step, we have no information about the relative positioning of NT on the 
surface of PX, although the lack of significant 15N and 1H shifts associated with this step 
indicate that it is highly likely that it is dynamic. The second, faster step induces significant 
15N and 1HN shifts, with the latter reporting on specific binding of one side of the helix in the 
inter-helical groove on the surface of PX. Remarkably, the rate associated with this second 
step corresponds closely to the intrinsic conformational exchange rate observed in the helical 
groove, providing strong evidence that the initial encounter complex is stabilized at a rate 
dictated by the intrinsic host protein dynamics.  
This study thus provides experimental evidence of an IDP interaction mechanism comprising 
two distinct steps. The rapidly exchanging free-state equilibrium sampled by NT is 
repopulated upon initial encounter with PX, such that only one helix is present on the surface 
of PX. Note that we cannot distinguish from the experimental data alone whether 
stabilization of H2 occurs uniquely through binding of this helical state in a conformational 
selection-type mechanism, or whether the individual states can each form H2 after 
encountering PX.22,24 In either case the overall scenario is retained, consisting of funneling 
the initial conformational equilibrium into a state resembling H2 in the encounter complex. 
The final bound state is however not achieved via this initial encounter interaction, which 
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remains non-specific until the second binding event specifically locates NT into the helical 
groove on the surface of PX.  
The possible thermodynamic advantages of formation of a non-specific encounter complex 
facilitating subsequent localization in the specific partner binding site have been discussed 
extensively.22,24,28 In the case of the NT:PX interaction, stabilization of the pre-formed helix 
presents the advantage that native contacts can be rapidly formed when the final interaction 
site is located on the surface of PX, a mechanism that is evidently energetically more 
favorable than complete folding upon binding from the disordered state. The first step, 
involving stabilization of an existing helical conformation, apparently incurs low enthalpic 
cost, and is rather associated with a loss of entropy due to depopulation of the more 
disordered elements of the free state equilibrium. The second step is then driven by the 
enthalpic benefit associated with formation of specific interactions within the PX binding 
site.  
Interestingly, NMR and stopped-flow studies of the intrinsically disordered ACTR protein, 
that folds upon binding to its partner NCBD, were used to demonstrate an acceleration of 
ligand binding as a function of intrinsic helical content,57 in agreement with our observation 
that the helical population present in the free-state equilibrium of NT is important for 
binding. The atomic resolution conformational and thermodynamic analysis presented here 
provides a mechanistic framework for these observations. By contrast time-resolved stopped-
flow  measurements, combined with circular dichroism and site-directed mutagenesis, 
recently indicated that residual structure is not required for binding of the disordered protein 
PUMA to its partner,58 indicating rather the presence of a single step, induced-fit type of 
mechanism. Our analysis of NT:PX reveals a clear two-step process, the first of which shows 
clear stabilization of one of the existing sub-states present in the free-state equilibrium of NT.  
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It is also important to note that analysis of only a subset of our experimental data, for 
example 13C RD curves alone or individual titration measurements, can also be globally 
explained in terms of a single step mechanism, but that simple two-state models derived from 
13C’, 15N or 1HN clearly contradict each other, as well as the more complete data set. Only the 
combination of 13C’, 15N and 1HN measurements identifies distinct steps, reporting 
predominantly either on folding (13C’) or binding (15N and 1HN) events in the NT:PX 
interaction pathway. The intricate trajectory revealed by RD further underlines the 
complexity of possible binding mechanisms populating the IDP-interactome, and reiterates 
the necessity for detailed atomic resolution studies to provide mechanistic explanations for 
these different scenarios.  
In conclusion, multinuclear RD provides an atomic resolution map of the molecular 
recognition trajectory of intrinsically disordered NT from the highly dynamic free-state 
equilibrium to the PX-bound state, revealing a three state interaction process whose binding 
modes and kinetics are regulated by the intrinsic conformational equilibrium of NT and the 
dynamic behavior of PX. This approach, providing high-resolution structural and kinetic 
information about a complex folding and binding interaction trajectory, can be applied to a 
number of experimental systems to provide a general framework for understanding 
conformational disorder in biomolecular function, that will eventually inform rational drug 
intervention involving this enigmatic class of proteins.  
METHODS 
Sample preparation 
The NT domain comprising residues 401–524 of the nucleoprotein of Sendai virus (SeV) 
strain Harris, whose amino acid sequence corresponds to that of SeV Fushimi strain NT 
(UniProtKB accession number Q07097) except for the mutation E410K, as well as the PX 
domain comprising residues 474–568 of the phosphoprotein (UniProtKB P04859) of SeV 
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strain Harris, were expressed and purified as described previously.48 For preparation of NMR 
samples of 13C,15N isotope-labeled NT complexed with unlabeled PX, stock solutions of 208 
µM 13C,15N-NT and 1.15 mM PX were used, both in 50 mM sodium phosphate buffer at pH 
6.0 with 500 mM NaCl. The NT stock also contained 9.5% D2O (vol/vol). From these stocks, 
admixtures of NT with 2, 3.5, 5, 8 and 15% PX (mol/mol) were made. Final NT:PX 
concentrations in these admixtures (in µM) were 204:4.1, 176:6.2, 199:9.9, 194:15.5 and 
183:27.5, respectively. NMR experiments on free NT were recorded on a sample at a 
concentration of 305 µM. For samples of 15N isotope-labeled PX alone or complexed with 
unlabeled NT, a stock solution of 408 µM 15N-PX in 50 mM sodium phosphate, 500 mM 
NaCl, 1 mM DTT and with 9.5% D2O (vol/vol) at pH 6.0 was used. Appropriate amounts of 
a 286 µM stock solution of unlabeled NT (in 50 mM sodium phosphate, 500 mM NaCl, pH 
6.0) were added to yield 15N-PX samples with 5, 8, and 15% NT (mol/mol), respectively 
(final PX: NT concentrations in µM: 378:18.8, 363:29, 331:49.6).  
NMR spectroscopy 
NMR experiments were performed at sample temperatures of 25°C on Varian/Agilent 
VNMRS 600 and 800 MHz spectrometers using room-temperature as well as cryogenically 
cooled triple-resonance HCN probes. All RD experiments employed constant-relaxation-time 
Carr-Purcell-Meiboom-Gill (CPMG) pulse schemes in which a series of 2D 15N-1H 
correlation spectra with different CPMG frequencies νCPMG = 1/(2τCP) were recorded, where 
τCP is the spacing between successive 180° refocusing pulses. Amide 15N and 1HN as well as 
carbonyl 13C’ RD profiles were recorded using pulse sequences described in the literature.59–
61 In the 15N dispersion experiment, 1H continuous-wave decoupling was applied during the 
CPMG period. Typically, 10–14 points (including 1 or 2 duplicates for error analysis) were 
recorded for each dispersion curve, corresponding to νCPMG frequencies between 31.25 and 
1000 Hz (15N), 100 and 2000 Hz (1H), and 66.7 and 933 Hz (13C) at total constant-time 
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relaxation delays (Trelax) of 32 ms, 20 ms, and 30 ms for 15N, 1HN, and 13C’ measurements, 
respectively. Spectra were usually acquired using sweep widths of 7.5 and 1.35 kHz as well 
as 512 and 120 complex points in 1H and 15N dimensions, respectively (at 600 MHz 1H 
spectrometer frequency). To obtain the signs of chemical shift differences for 15N, 1HN, and 
13C’ nuclei, HSQC (15N, 1HN) or HNCO (13C’) spectra at different static magnetic fields were 
recorded, as well as pairs of HSQC/HMQC spectra (15N, 1HN) and pairs of HNCO spectra 
with single- or multiple-quantum 15N-13CO coherence evolution (13C’) at the same field.54 
Data analysis 
Spectra were processed using NMRPipe62 and analyzed in Sparky.63 Relaxation dispersion 
profiles (R2,eff(νCPMG)) were calculated from peak heights according to R2,eff(νCPMG) = -1/Trelax 
ln(I(νCPMG)/I0) with I(νCPMG) the peak height in the spectrum recorded with CPMG frequency 
νCPMG and I0 the peak height in a reference spectrum recorded without a CPMG pulse train. 
Errors ΔR2,eff in R2,eff values were calculated as ΔR2,eff(νCPMG) = σ/(Trelax I(νCPMG)) with σ the 
pooled standard deviation of peak heights in duplicate measurements.64  
Relaxation dispersion curves were first analyzed using the software CATIA,52 
http://pound.med.utoronto.ca/~flemming/catia/) performing numerical integration of the 
Bloch-McConnell equations for a 2-state exchange model. Dispersion profiles from 
individual residues and nuclei measured at two static magnetic fields were fit assuming 
exchange (i.e. using CATIA) as well as assuming no exchange (i.e. to a constant value of 
R2,eff). Dispersion profiles were retained for further analysis if (a) assuming exchange 
improved the fit at the 99% confidence level according to F test statistics, (b) the difference 
between R2,eff values at minimum and maximum νCPMG values was at least 2 s-1 (15N, 13C) or 
3 s-1 (1HN) at least at one static magnetic field, and (c) the average ΔR2,eff error value of a 
dispersion profile was not larger than 25% at both static magnetic fields or not larger than 
15% at least at one field. In the case of data recorded on labeled PX complexed with 
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unlabeled NT, the presence of dispersion from fast exchange already in free PX 55 constitutes 
an additional complication. To analyze only dispersion processes related to NT binding, only 
such R2,eff profiles were retained that exhibited dispersion not present in the absence of NT or 
significantly different (as judged from fitting the R2,eff  difference profile) from that present 
without NT.  
All available dispersion curves originating from individual peptide planes (i.e. amide 15N and 
1HN data for residue i and carbonyl 13C’ data for residue i-1) retained as described above were 
then fit together for each peptide plane separately to yield residue-specific values of exchange 
rate constant kex, minor state population pB, chemical shift differences Δω between major and 
minor state for the respective nuclei and intrinsic transverse relaxation rate R2,0 for each 
residue and nucleus at each field and each admixture. Further analysis of these dispersion 
profiles involved (a) fitting individual residues comprising data from all nuclei at all 
admixtures, assuming (residue-specific) kex and Δω values to be constant across admixtures, 
but allowing pB to vary, using in-house software employing the analytical Carver-Richards 
equation65 (b) combined fitting of data from all nuclei and all residues at a given admixture of 
the two partner proteins to yield global values of kex and pB, using numerical integration by 
CATIA for 2-state exchange; (c) combined fitting of all nuclei and all residues at a given 
admixture to a model of 3-state exchange, by way of numerical integration of the Bloch-
McConnell equations using the software cpmg_fitd9 66 kindly provided by Dmitry Korzhnev 
(d) combined fitting of all nuclei and all residues at all admixtures to a model of linear 3-state 
exchange, assuming constant values of kex and Δω for the two exchange processes across 
different admixtures, but allowing pB to vary with admixtures and R2,0 to vary with each 
dataset, by numerical integration of the Bloch-McConnell equations using home-written 
software and finally (e) the program ChemEx67 kindly provided by Guillaume Bouvignies, 
was used to cross check results derived from (a-d). Results were found to be entirely 
consistent within the different programs. The quality of fits was assessed using chi-squared 
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statistics. Note that forked 3-state models were not pursued, due to the intuitive nature of the 
linear models allowing for a more straightforward interpretation in terms of structural and 
kinetic parameters. 
The parameter space for fits to dispersion data assuming 3-state exchange is vast, comprises 
many local minima and often exhibits correlations between parameters, such that different 
parameter sets can yield fits with similar chi-squared statistics. We narrowed down the space 
of possible solutions by first considering only the admixture of NT with 5% PX, for which 
the CPMG experiments yielded the best compromise between signal-to-noise and number of 
analyzable resonances on the one hand as well as dynamic range of R2,eff values on the other 
hand. We initially required that the total excited-state population (pB+pC) did not exceed the 
relative amount of added binding partner (i.e. 5% in this case) and that no exchange rate in 
the resultant model exceeded 3000 s-1. Convergence was obtained by fixing the sum of pB 
and pC to 5% which, given the precision of the fit, is justified based on the measurement of 
Kd of the NT-PX interaction in the low micromolar range (Fig. S2). The resultant model of a 
3-state linear exchange has exchange rates of kex,AB=(852±31)s-1 and kex,BC=(2600±493)s-1 as 
well as excited-state populations of pB=3.7±0.1% and pC=1.3±0.1% (at the NT admixture 
with 5% PX). An extended grid search with less stringent requirements on resultant kex 
values (cutoff at 4000s-1, above the sensitivity limit of CPMG experiments) consistently 
yielded a value of kex,AB in the range of the kex found in 2-state fits as well as 13C’ chemical 
shift changes between states A and B corresponding to those extracted from 2-state fits, as is 
the case for the 3-state model described above. We then tested the validity of this minimum 
by fixing kex,AB to 850 s-1 and fitting populations, chemical shifts, and kex,BC as free 
parameters. This again localized a global minimum over the resultant parametric space in the 
combination kex,AB, kex,BC (850, 2650) and pB, pC (0.35, 0.15). 
Importantly dispersion data at the other admixtures yielded very good fits using this exchange 
model (with kex,AB and kex,BC fixed) based on chi-squared statistics (Table 1) and resulted in 
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pB and pC values in the range expected from the Kd of the interaction (Fig. 5). Finally, we 
have analyzed data from all admixtures simultaneously using in-house software, in this case 
fitting kex,AB, kex,BC globally, pB, pC for each admixture and the chemical shifts for each site 
treated globally. 
To obtain Δω values also for those residues of the PX binding site of NT whose dispersion 
curves did not meet the significance criteria described above, we ran fits (assuming 2- and 3-
state exchange) to data from all residues of this region, fixing global parameters (kex and pB 
for 2-state exchange, kex,AB, kex,BC, pB, pC for 3-state exchange) to the values obtained using 
only CPMG data exhibiting significant dispersion, for each admixture separately.  
Signs of chemical shift differences for 13C nuclei (assuming 2-state exchange) were obtained 
by comparing resonance positions in pairs of HNCO spectra with single- or multiple-
quantum 15N-13CO coherence evolution (13C)54 and in spectra containing different amounts of 
unlabeled partner protein. The visible resonance should be closer to the excited-state 
resonance peak in the single-quantum spectrum and in the spectrum with a larger amount of 
binding partner, respectively. Chemical shift differences were considered significant if their 
absolute value exceeded the mean plus one standard deviation of all chemical shift 
differences between corresponding peaks; in addition, shift differences smaller than 1 Hz 
were not considered significant.  
Ensemble calculations using ASTEROIDS 
In order to model the conformational ensemble of NT when bound to PX, we applied the 
minimum ensemble approach46 implemented in a version of the ASTEROIDS genetic 
algorithm for ensemble selection,68–70 with NT 13C’ shifts in complex as selection criteria.47,71 
13C’ shifts of PX-complexed NT were generated as the sum of free-state 13C’ chemical shifts 
and 13C’ Δω values as obtained from the fit of the canonical model of 3-state exchange to RD 
data (weighted means over results from individual admixtures). A common empirical 
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correction of -0.25 ppm was applied to all free-state 13C’ NT chemical shifts following 
calibration of ASTEROIDS ensemble selection against the free-state 13C’ shifts compared to 
the known total helical content of the central binding site of free NT (75% in residues 479-
484).46  
We used an existing flexible-meccano72,73 ensemble of NT conformers containing sub-
ensembles for all possible helices (4 to 20 residues in length) covering residues 476 – 495 as 
well as a fully unfolded sub-ensemble, yielding a total of 154 sub-ensembles with 1000 
conformers each.46 Chemical shifts were calculated for all conformers using SPARTA 74 and 
averaged over sub-ensembles. ASTEROIDS was run to obtain the weighted combination of 
unfolded and helical ensembles yielding the best fit to the experimental 13C’ chemical shift 
data, for increasing numbers of helical conformers (n = 1, 2, 3, 4), similar to the approach 
using residual dipolar coupling data as described.46 Each helical conformer thus introduced 
three parameters into the fit (helix start, end, and population). The data could well be fit 
assuming a single helix extending between residues 476 and 489, very similar to helix H2 of 
the free state,46 populated to 100%. No improvement (p > 0.1) was obtained with ensembles 
with more helical contributions, or with a population of an unfolded conformer.  
Analysis of mutational studies of NT:PX interaction 
In order to perturb the observed interaction kinetics in a controlled way, two key mutations 
were made to NT, replacing Asp475 and Asp478 by alanines. 15N, 1HN, and 13C’ RD 
measurements were made at concentrations of mutant NT of 190µM and PX of 6.7µM (0.035 
molar ratio of PX), and compared to those measured using wild type NT at the same molar 
ratio of PX. Two-state global fits to all residues and nuclei of mutant NT showing dispersion 
yielded an exchange rate kex=(247±33)s-1 and a bound state population of pB=(2.7±0.3)%. 
This value of pB would correspond to a Kd of 55µM (calculated as Kd = (1-pB)･([P0]/pB-[N0]), 
with [P0] and [N0] the total concentrations of PX and NT respectively). Using this Kd 
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estimate to calculate the concentration of free PX ligand [P], an estimate of kon can be 
calculated as kon=kex/([P]+Kd), yielding a value of 4.4･106 M-1s-1 for the NT mutant. The 
same calculation using the exchange rate for the binding step of wild-type NT to PX derived 
from the 3-state fit to NT RD data (kex,AB=852s-1) and the upper limit of the corresponding Kd 
of 60µM yields a kon value of 1.4･107 M-1s-1 using the concentrations of the NT admixture 
with 3.5% PX, while the experimentally determined Kd of 8µM (Fig S2) gives a kon value of 
4･107 M-1s-1. 
Isothermal titration calorimetry 
ITC measurements were performed on the MicroCal iTC200 (GE Healthcare, PA) at 25°C. 
Prior to the experiment, the proteins were dialyzed into the same ITC buffer (50 mM sodium 
phosphate pH 6.0, 500 mM NaCl, 2 mM β-mercaptoethanol). PX at a concentration of 
750µM was titrated into a solution of NT at a concentration of 50µM. A total of 24 injections 
of 1.5µl were performed every 180 seconds at a stirring speed of 800 rpm. Data were 
analyzed using Origin (OriginLab, Northampton, MA) and yielded a dissociation constant of 
(8.4±0.9)µM.  
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Figure Legends 
Figure 1  
13C and 15N R2,eff dispersion curves for selected residues measured at 14.1 and 18.8 T (600 
and 800 MHz 1H Larmor frequency) for 2 (green), 3.5 (blue), 5 (orange) and 8 (red) % molar 
ratio admixtures of PX:NT. Data from the 15% admixture and 1HN data are not shown in the 
interests of space. Residue number i refers to the peptide plane containing the amide group of 
residue i and the carbonyl carbon of residue i-1. 
Figure 2  
Kinetic parameters derived from analysis of RD data using a 2-state model. 
A - Exchange rate (kex) determined from residue specific fitting of RD curves derived from 
all residues in the helical region from admixtures containing 2, 3.5, 5 and 8% PX using the 
Carver-Richards expression for two-site exchange. Data from all admixtures and all nuclei 
were fitted simultaneously.  
B – Residue-specific exchange rates kex and excited state populations pB for residues in the 
PX binding site of NT, color-coded by admixture (red - 2%, green - 3.5%, blue - 5%), 
obtained by fits of individual residue data to a 2-state exchange model (Fig. S5). 
C – Dependence of kex values on molar ratio. Blue: kex measured for NT with respect to 
[PX]:[NT] molar ratio. kex values were obtained from global fits of a 2-state exchange model 
to NT 13C’, 15N, and 1HN RD data at individual titration mixtures. Data can be fit using a 
constant kex=(771±38)s-1. Red: kex measured on PX with respect to [NT]:[PX] molar ratio. kex 
was obtained from global fits of 2-state exchange model to 15N and 1HN RD data from all 
sites on PX exhibiting exchange in the presence of NT, but not in the absence of NT. Data 
can be fit with a constant value of kex=(803±37) s-1. 
Figure 3  
Examples of the improvement in the reproduction of RD data from some sites when fitting all 
data from a single admixture assuming a single global 2-state exchange process and when 
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fitting all data from a single admixture assuming a single global 3-state kinetic model. 
Experimental 15N RD data (red points) are shown for residue 484, for the 5% PX:NT 
admixture (blue - 2-state fit, as shown in Fig S7, red - 3-state as shown in Fig 3A.). Left hand 
figure shows data measured at 14.1 T, right hand figure shows data measured at 18.8 T. 
Figure 4 
Three-state characterization of the NT:PX interaction from RD. 
Examples of fits to RD curves from NT. All data from each peptide plane in helical region 
were simultaneously fitted by numerical integration of the Bloch-McConnell equations for 3-
state exchange with rates kex,AB and kex,BC (852s-1, 2600s-1). Solid lines - fitted curves, circles 
- data points (red – 14.1T, blue 18.8T). 
Figure 5 
Population of the PX-bound form of NT (red) determined from a simultaneous analysis of all 
residues showing dispersion as a function of [PX]:[NT] molar ratio. Blue line indicates the 
calculated pB assuming a dissociation constant of (8.4±0.9)µM as estimated from ITC 
measurements (Fig. S2). Solid red line shows the fitted (pB+pC) values from the 3-state fit 
(note that for the 5% data set pB+pC was fixed to 5% as described in Methods). 
Figure 6 
Structural changes accompanying three-state exchange model for the NT:PX interaction. 
A - Comparison of Δω(13C’) derived from 3-state fits. ΔωAB from independent admixtures 
(molar ratios 0.02, 0.035, 0.05 and 0.08 - red dashed lines) and their weighted mean (red 
solid line) compared to ΔωAB derived from analysis of all admixtures simultaneously (blue 
solid line). 
B – Comparison of Δω(15N) derived from the 3-state fit from molar ratio admixtures 0.02, 
0.035, 0.05 and 0.08. ΔωAC from independent admixtures (blue lines) compared to ΔωAB 
from the same analysis (red lines).  
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C - Comparison of Δω(1HN) derived from the 3-state fit. Weighted mean and errors (blue 
line) of ΔωAC derived from analysis of all admixtures, compared to weighted means of ΔωAB 
(red line).  
Figure 7 
Structural analysis of the different steps of NT binding to PX 
A – Sum of 13C’ secondary chemical shifts of the free-state equilibrium and ΔωAB (bars) and 
ASTEROIDS minimum ensemble selection against these shifts (blue). A single ensemble 
sub-state, reporting on helix 476-489 populated to 100% best reproduces the experimental 
data. The 476-489 helical sub-ensemble is shown in cartoon representation above, 
corresponding closely to the H2 helix (476-488), populated to 30% in the free-state ensemble. 
Blue residues show Δω(1HN) values > 0.4ppm. 
B – Mapping the binding site of NT with PX. Ribbon representation of NT sites showing 1HN 
RD derived shifts (blue) greater than the threshold (ΔωAC 1HN > 0.4ppm). Ribbon 
representation of PX shows the residues (red) displaying significant 15N or 1HN RD or 
significant shifts at all admixtures of NT. Numbers show positions of residues on PX (red) 
and NT (blue) residues exhibiting dispersion. The orientation of NT with respect to PX was 
optimized to agree with observed chemical shifts. 
Figure 8  
Proposed binding mechanism for Sendai virus NT to PX.  
The underlying conformational equilibrium in the free state, populating three helices (H1, H2 
and H3, populations of the total bound form shown in parentheses) and the unfolded form 
(U), binds to PX via an initial encounter complex that repopulates the equilibrium by 
stabilizing a helix resembling H2 with a rate of 850s-1. Although the nature of the 
conformation of NT in the encounter complex is known, its position relative to PX is 
unknown in this step, although the lack of significant 15N and 1H shifts associated with this 
step indicate that it is highly likely that to be dynamic. This is indicated by the ‘fuzzy’ nature 
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of cartoon in the intermediate step. The association rate of this step is estimated to be faster 
than the diffusion limit, indicating that this encounter complex is electrostatically driven, a 
prediction supported by mutation studies. Following the encounter, the helix locks into the 
PX binding site located in the helical groove on the surface of PX at a rate (2600 s-1) 
coincident with intrinsic motions of the PX helices. A sketch of the free-energy landscape 
showing that the encounter step has a higher population than the second, more specific step is 
shown based on populations from p=0.05 admixture.  
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Admixture N data 
N(param) 
2-state 
N(param) 
3-state 
χ2  
2-state 
χ2  
3-state 
F-test P 
 
2.0% 
 
678 
 
101 
 
134 
 
526.30 
 
488.80 
 
1.265 
 
0.16 
3.5% 726 101 134 740.50 677.51 1.668 0.01 
5.0% 609 89 118 534.49 456.46 2.894 <0.0001 
8.0% 556 80 106 420.54 353.60 3.276 <0.0001 
15.0% 447 65 86 479.36 399.81 3.420 <0.0001 
  
Table 1: Comparison of goodness of fit parameters for the global 2-state and global 3-state 
fits of data measured from NT at each different admixture of PX. In all cases except for the 
2.0% admixture the 3-state fit is significantly better than the 2-state fit. The lack of 
significance in improvement for this admixture is probably due to signal to noise, related to 
the small amplitude of the RD effects at the lowest admixture. 
 
  
 37 
 
TOC 
 
 
 
 
 
